FDA Drug recall D-0215-2016
ESTRIOL (E3) : PROGESTERONE : DHEA (Dehydroepiandrosterone Micronized) W/V (weight/volume) VERSABASE 4.0 : 30 : 4MG/ML Transdermal cream, d…
- FDA Drug
- Class II
- terminated
- Published 2015-11-18
On 2015-11-18 the FDA classified a Class II recall of ESTRIOL (E3) : PROGESTERONE : DHEA (Dehydroepiandrosterone Micronized) W/V (weight/volume) VERSABASE 4.0 : 30 : 4MG/ML Transdermal cream, d… by The Compounder, citing recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0215-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-03-10 |
| Published | 2015-11-18 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | The Compounder |
| Distribution | US |
Product
ESTRIOL (E3) : PROGESTERONE : DHEA (Dehydroepiandrosterone Micronized) W/V (weight/volume) VERSABASE 4.0 : 30 : 4MG/ML Transdermal cream, dispensed in 10 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.
Reason
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Identifiers
| code_info | Lot # 01282015:71@21, Exp 7/27/2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0215-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.